Cargando…

A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer

Purpose: The aims of the present study were to explore immune-related genes (IRGs) in stage IV colorectal cancer (CRC) and construct a prognostic risk score model to predict patient overall survival (OS), providing a reference for individualized clinical treatment. Methods: High-throughput RNA-seque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ke, He, Jie, Zhang, Jie, Liu, Tao, Yang, Fang, Ren, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584813/ https://www.ncbi.nlm.nih.gov/pubmed/33034614 http://dx.doi.org/10.1042/BSR20201725

Ejemplares similares

Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer
por: Liu, Bo, et al.
Publicado: (2021)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

Data mining of immune-related prognostic genes in metastatic melanoma microenvironment
por: Han, Wei, et al.
Publicado: (2020)

Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature
por: Venderbosch, Sabine, et al.
Publicado: (2011)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis
por: Ye, Zu‐Lu, et al.
Publicado: (2019)

Prediction of prognosis of patients with lung cancer in combination with the immune score
por: Han, Ke, et al.
Publicado: (2021)

The Prognostic Value of a Geriatric Risk Score for Older Patients with Colorectal Cancer
por: Souwer, E. T. D., et al.
Publicado: (2018)

Immune implication of an autophagy-related prognostic signature in uveal melanoma
por: Chuah, Samuel, et al.
Publicado: (2021)

SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma
por: Guo, Tao, et al.
Publicado: (2022)

Development of a risk score for colorectal cancer in Chinese males: A prospective cohort study
por: Guo, Lanwei, et al.
Publicado: (2019)

Inflammation-Immunity-Nutrition Score: A Novel Prognostic Score for Patients with Resectable Colorectal Cancer
por: Li, Xin-Ying, et al.
Publicado: (2021)

Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)

A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma
por: Kudchadkar, Ragini, et al.
Publicado: (2015)

Strategy to targeting the immune resistance and novel therapy in colorectal cancer
por: Gang, Wang, et al.
Publicado: (2018)

Correlation of immune infiltration with clinical outcomes in breast cancer patients: The 25‐gene prognostic signatures model
por: Liu, Yushan, et al.
Publicado: (2021)

Clinicopathologic features and prognostic value of KRAS, NRAS and BRAF mutations and DNA mismatch repair status: A single‐center retrospective study of 1,834 Chinese patients with Stage I–IV colorectal cancer
por: Guo, Tian‐An, et al.
Publicado: (2019)

Identification of three m6A‐related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma
por: Li, Zedong, et al.
Publicado: (2020)

Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Li, Fazhan, et al.
Publicado: (2021)

Prognostic nomogram based on immune scores for breast cancer patients
por: Wang, Ju, et al.
Publicado: (2019)

Commentary on: Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Chen, Kexin, et al.
Publicado: (2021)

Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
por: Shao, Jun, et al.
Publicado: (2020)

Cancer‐associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases
por: Brown, Kai M., et al.
Publicado: (2021)

Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences
por: Fan, Tao, et al.
Publicado: (2021)

A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma
por: Luo, Xuehui, et al.
Publicado: (2022)

Evaluating the prognostic contributions of TNM classifications and building novel staging schemes for middle ear squamous cell carcinoma
por: Qiu, Ke, et al.
Publicado: (2021)

An immune‐related prognostic signature for predicting breast cancer recurrence
por: Tian, Zelin, et al.
Publicado: (2020)

Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma
por: Tian, Wei, et al.
Publicado: (2023)

Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment
por: Wu, Beilei, et al.
Publicado: (2020)

WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2021)

A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy
por: Liang, Jie‐ying, et al.
Publicado: (2021)

Seven immune‐related genes prognostic power and correlation with tumor‐infiltrating immune cells in hepatocellular carcinoma
por: Liu, Tiantian, et al.
Publicado: (2020)

Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma
por: Liu, Jie, et al.
Publicado: (2020)

Efficacy of surgery and chemotherapy for stage IV small bowel adenocarcinoma: A population‐based analysis using Surveillance, Epidemiology, and End Result Program database
por: Liu, Tongtong, et al.
Publicado: (2020)

Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
por: Li, Yaqi, et al.
Publicado: (2020)

Prognostic and predictive values of tumour budding in stage IV colorectal cancer
por: Nagata, K., et al.
Publicado: (2020)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
por: Shen, Xianjuan, et al.
Publicado: (2020)

A signature of 33 immune‐related gene pairs predicts clinical outcome in hepatocellular carcinoma
por: Sun, Xiao‐Yan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nq7qf38g3ne111004ui1kgkvo1